JP2020510816A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020510816A5 JP2020510816A5 JP2019542716A JP2019542716A JP2020510816A5 JP 2020510816 A5 JP2020510816 A5 JP 2020510816A5 JP 2019542716 A JP2019542716 A JP 2019542716A JP 2019542716 A JP2019542716 A JP 2019542716A JP 2020510816 A5 JP2020510816 A5 JP 2020510816A5
- Authority
- JP
- Japan
- Prior art keywords
- sftbp
- cyfra21
- pro
- cea
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762456731P | 2017-02-09 | 2017-02-09 | |
| US62/456,731 | 2017-02-09 | ||
| PCT/US2018/017704 WO2018148600A1 (en) | 2017-02-09 | 2018-02-09 | Methods for the detection and treatment of lung cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020510816A JP2020510816A (ja) | 2020-04-09 |
| JP2020510816A5 true JP2020510816A5 (https=) | 2021-03-25 |
| JP7311417B2 JP7311417B2 (ja) | 2023-07-19 |
Family
ID=63107741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019542716A Active JP7311417B2 (ja) | 2017-02-09 | 2018-02-09 | 肺癌の検出および処置のための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US12504430B2 (https=) |
| EP (2) | EP4528741A3 (https=) |
| JP (1) | JP7311417B2 (https=) |
| KR (2) | KR102827354B1 (https=) |
| CN (2) | CN110291397A (https=) |
| CA (1) | CA3053116A1 (https=) |
| ES (1) | ES2995959T3 (https=) |
| WO (1) | WO2018148600A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110291397A (zh) | 2017-02-09 | 2019-09-27 | 得克萨斯大学体系董事会 | 肺癌的检测和治疗方法 |
| WO2021016711A1 (en) * | 2019-07-29 | 2021-02-04 | Biomark Cancer Systems Inc. | Method of discriminating lung cancer patients |
| CA3165068A1 (en) | 2020-01-30 | 2021-08-05 | John E. Blume | Lung biomarkers and methods of use thereof |
| EP4143578B1 (en) * | 2020-04-28 | 2024-06-05 | Luxembourg Institute of Health (LIH) | Biomarkers for detection of lung cancer |
| WO2022051753A1 (en) * | 2020-09-01 | 2022-03-10 | Oncodea Corporation | Predictive diagnostic test for early detection and monitoring of diseases |
| CN112147099A (zh) * | 2020-09-22 | 2020-12-29 | 范庆坤 | 一种m蛋白紫外分光检测法 |
| KR20230080442A (ko) * | 2020-10-02 | 2023-06-07 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 폐암의 검출 및 치료를 위한 방법 |
| EP4237090B1 (en) * | 2020-10-29 | 2026-02-18 | Board of Regents, The University of Texas System | Methods for the detection and treatment of ovarian cancer |
| AU2021409465A1 (en) | 2020-12-21 | 2023-08-03 | Freenome Holdings, Inc. | Markers for the early detection of colon cell proliferative disorders |
| US12334190B2 (en) | 2021-03-31 | 2025-06-17 | PrognomIQ, Inc. | Multi-omic assessment using proteins and nucleic acids |
| GB2607436A (en) * | 2021-03-31 | 2022-12-07 | Prognomiq Inc | Multi-omic assessment |
| CN113267587B (zh) * | 2021-05-27 | 2023-11-10 | 杭州广科安德生物科技有限公司 | 测定pro-SFTPB标准物质含量的特征肽段及方法 |
| US12387508B2 (en) | 2021-09-10 | 2025-08-12 | PrognomIQ, Inc. | Direct classification of raw biomolecule measurement data |
| US12007397B2 (en) | 2021-09-13 | 2024-06-11 | PrognomIQ, Inc. | Enhanced detection and quantitation of biomolecules |
| WO2023209218A1 (en) * | 2022-04-28 | 2023-11-02 | Janssen Pharmaceutica Nv | Metabolite predictors for lung cancer |
| EP4357782A1 (en) * | 2022-10-18 | 2024-04-24 | MU Bioteknik Aktiebolag | Protein biomarker panel for the diagnosis of colorectal cancer |
| CN115575636B (zh) * | 2022-11-22 | 2023-04-04 | 杭州广科安德生物科技有限公司 | 一种用于肺癌检测的生物标志物及其系统 |
| CN116593702B (zh) * | 2023-05-11 | 2024-04-05 | 杭州广科安德生物科技有限公司 | 一种肺癌的生物标志物以及诊断系统 |
| WO2025064345A2 (en) * | 2023-09-22 | 2025-03-27 | Board Of Regents, The University Of Texas System | Methods for the detection and treatment of lung cancer |
| CN118983078B (zh) * | 2024-08-15 | 2025-03-25 | 立本医疗器械(成都)有限公司 | 基于ptr-tof-ms的肺癌筛查模型构建方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1969363B1 (en) * | 2005-12-22 | 2016-11-30 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
| US9347945B2 (en) | 2005-12-22 | 2016-05-24 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
| US20080133141A1 (en) * | 2005-12-22 | 2008-06-05 | Frost Stephen J | Weighted Scoring Methods and Use Thereof in Screening |
| CA2681667A1 (en) * | 2007-05-18 | 2008-11-27 | Duke University | Serum biomarkers for the early detection of lung cancer |
| WO2012006632A2 (en) | 2010-07-09 | 2012-01-12 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| EP2567232A1 (en) * | 2010-05-07 | 2013-03-13 | AbbVie Inc. | Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor |
| US20120087860A1 (en) * | 2010-05-24 | 2012-04-12 | Marek Malecki | Methods for in vivo cancer detection, diagnosis and therapy using multidomain biotags |
| WO2011150974A1 (en) | 2010-06-03 | 2011-12-08 | Porto Conte Ricerche S.R.L. | Biomarkers for lung neuroendocrine tumors |
| CN102321760A (zh) * | 2011-08-26 | 2012-01-18 | 泸州医学院附属医院 | 一种非小细胞肺癌标志物及应用 |
| CA2799163C (en) * | 2011-12-18 | 2025-01-07 | 20/20 Genesystems, Inc. | Methods and algorithms for aiding in the detection of cancer |
| WO2013154998A1 (en) | 2012-04-09 | 2013-10-17 | Duke University | Serum biomarkers and pulmonary nodule size for the early detection of lung cancer |
| US20140271453A1 (en) * | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Methods for the early detection of lung cancer |
| US9753037B2 (en) | 2013-03-15 | 2017-09-05 | Rush University Medical Center | Biomarker panel for detecting lung cancer |
| US20150072890A1 (en) * | 2013-09-11 | 2015-03-12 | 20/20 Gene Systems, Inc. | Methods and compositions for aiding in the detection of lung cancer |
| US20160060329A1 (en) * | 2014-07-28 | 2016-03-03 | Donald SIN | Compositions and methods for the diagnosis and prognosis of lung cancer |
| CA3198282A1 (en) * | 2015-06-26 | 2016-12-29 | Biomark Cancer Systems Inc. | Method of detecting lung cancer |
| EP3427051B1 (en) | 2016-03-08 | 2021-06-16 | Magarray, Inc. | Protein and autoantibody biomarkers for the diagnosis and treatment of lung cancer |
| CN105717146B (zh) * | 2016-03-29 | 2018-11-09 | 复旦大学附属中山医院 | 一种基于ct影像及生物标志物谱针对中国城市人口高危人群的肺癌风险预测试剂盒 |
| CN109478231A (zh) | 2016-04-01 | 2019-03-15 | 20/20基因系统股份有限公司 | 帮助区别良性和恶性放射线照相明显肺结节的方法和组合物 |
| EP3361256A1 (en) | 2017-02-08 | 2018-08-15 | Fundación para la Investigación Médica Aplicada | In vitro method for the diagnosis of lung cancer |
| CN110291397A (zh) | 2017-02-09 | 2019-09-27 | 得克萨斯大学体系董事会 | 肺癌的检测和治疗方法 |
| IL319255A (en) | 2017-08-07 | 2025-04-01 | Univ Johns Hopkins | Methods and materials for cancer assessment and treatment |
| KR20230080442A (ko) | 2020-10-02 | 2023-06-07 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 폐암의 검출 및 치료를 위한 방법 |
| WO2024107923A1 (en) | 2022-11-17 | 2024-05-23 | Board Of Regents, The University Of Texas System | Methods for the detection and treatment of lung cancer |
| TR2022022101A2 (tr) | 2022-12-31 | 2023-04-24 | Atatuerk Ueniversitesi Fikri Muelkiyet Haklari Koordinatoerluegue Doener Sermaye Isletmesi | Nemlendi̇ri̇ci̇ modelaj örtüsü |
| EP4721103A2 (en) | 2023-05-31 | 2026-04-08 | Board of Regents, The University of Texas System | Methods for the detection and treatment of lung cancer |
| WO2025064345A2 (en) | 2023-09-22 | 2025-03-27 | Board Of Regents, The University Of Texas System | Methods for the detection and treatment of lung cancer |
-
2018
- 2018-02-09 CN CN201880010925.0A patent/CN110291397A/zh active Pending
- 2018-02-09 CA CA3053116A patent/CA3053116A1/en active Pending
- 2018-02-09 EP EP24204031.9A patent/EP4528741A3/en not_active Withdrawn
- 2018-02-09 EP EP18752036.6A patent/EP3580560B1/en active Active
- 2018-02-09 KR KR1020247002923A patent/KR102827354B1/ko active Active
- 2018-02-09 KR KR1020197026040A patent/KR102630885B1/ko active Active
- 2018-02-09 ES ES18752036T patent/ES2995959T3/es active Active
- 2018-02-09 CN CN202311117176.0A patent/CN117368475A/zh active Pending
- 2018-02-09 US US16/484,177 patent/US12504430B2/en active Active
- 2018-02-09 WO PCT/US2018/017704 patent/WO2018148600A1/en not_active Ceased
- 2018-02-09 JP JP2019542716A patent/JP7311417B2/ja active Active
-
2023
- 2023-03-28 US US18/191,506 patent/US12405274B2/en active Active
-
2025
- 2025-11-10 US US19/384,269 patent/US20260063638A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020510816A5 (https=) | ||
| Zhao et al. | Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application | |
| Wei et al. | Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer | |
| Pan et al. | Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study | |
| EP3623814A2 (en) | Biomarker for monitoring or diagnosing onset of liver cancer in high-risk group for liver cancer and use thereof | |
| US8653006B2 (en) | Metabolite biomarkers for the detection of esophageal cancer using NMR | |
| JPWO2016163539A1 (ja) | 肝疾患の病態を判別する方法 | |
| JP2020514689A5 (https=) | ||
| CN113791219B (zh) | 用于急性缺血性脑卒中复发风险分析的生物标志物及其应用 | |
| Albrethsen | The first decade of MALDI protein profiling: a lesson in translational biomarker research | |
| Honda et al. | Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer | |
| Sahni et al. | A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma | |
| JP7179356B2 (ja) | 代謝物分析を利用したベーチェット病の診断方法 | |
| WO2019185692A1 (en) | Metabolite-based breast cancer detection and diagnosis | |
| CN106370744A (zh) | 8‑羟基脱氧鸟苷作为尿液标志物的应用 | |
| Yi et al. | Metabolomic identification of novel biomarkers of nasopharyngeal carcinoma | |
| Kim et al. | Differential levels of L-homocysteic acid and lysophosphatidylcholine (16: 0) in sera of patients with ovarian cancer | |
| Krishnan et al. | Circulating metabolite biomarkers: A game changer in the human prostate cancer diagnosis | |
| Liang et al. | Lipidomics analysis based on liquid chromatography mass spectrometry for hepatocellular carcinoma and intrahepatic cholangiocarcinoma | |
| Gîrleanu et al. | Platelet indices in patients with de novo portal vein thrombosis and liver cirrhosis | |
| Choi et al. | Evaluation of revisited fucosylated alpha-fetoprotein (AFP-L3) with an autoanalyzer μTAS in a clinical laboratory | |
| CN115684451A (zh) | 基于代谢组学的食管鳞癌淋巴结转移诊断标志物及其应用 | |
| Kohli et al. | Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for determining prognosis in advanced stage hormone relapsing prostate cancer | |
| KR20230113742A (ko) | 난소암의 검출 및 치료를 위한 방법 | |
| CN118658612A (zh) | 一种基于外泌体蛋白标志物的肺癌辅助诊断和预后评估的系统 |